首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5篇
  免费   0篇
林业   1篇
畜牧兽医   4篇
  2017年   1篇
  2009年   1篇
  2005年   1篇
  2004年   1篇
  1995年   1篇
排序方式: 共有5条查询结果,搜索用时 15 毫秒
1
1.
OBJECTIVE: To assess the safety of endoscopic retrograde pancreatography (ERP) in dogs by performing repeated clinical examinations and laboratory analyses of serum amylase, lipase, canine trypsin-like immunoreactivity (cTLI), and canine pancreatic elastase 1 (cE1) after the procedure. ANIMALS: 7 healthy Beagles. PROCEDURES: Clinical examinations were performed and blood samples obtained for serum enzyme determinations before and at intervals (10 minutes; 2, 4, and 6 hours; and 1, 2, and 3 days) after ERP. RESULTS: Repeated clinical examinations revealed no signs of ERP-induced complications in the 7 dogs. Results of repeated laboratory tests indicated a transient increase in serum values of amylase, lipase, and cTLI but not cE1. Mean +/- SD lipase activity increased from 120.7 +/- 116.4 U/L to 423.4 +/- 243.1 U/L at 4 hours after ERP. Median serum cTLI concentration increased from 16.2 microg/L (range, 77 to 26.5 microg/L) to 34.9 microg/L (range, 16.6 to 68.3 microg/L) 10 minutes after ERP. Enzyme values returned to baseline levels at the latest on day 2 in 6 of 7 dogs. Highest values for serum amylase, lipase, and cTLI and their delayed return to baseline values were detected in 1 dog with contrast filling of the pancreatic parenchyma. CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that ERP appears to be a safe imaging technique of pancreatic ducts in healthy dogs, although it induced a transient increase in serum values of pancreatic enzymes. In dogs, repeated clinical examinations and serum enzyme determinations can be used to monitor ERP-induced complications such as acute pancreatitis.  相似文献   
2.
Endoscopic retrograde cholangiography and pancreatography was performed in seven healthy Beagles to assess the common bile duct and the accessory pancreatic duct after retrograde filling with an iodine contrast medium. All dogs had a major and a minor duodenal papilla. One Beagle had additionally an accessory papilla. The diameter of the contrast filled ducts was measured at three defined measure points (MP1-3) in ventrodorsal radiographs and left lateral radiographs. In ventrodorsal radiographs of endoscopic retrograde cholangiography the common bile duct had a straight craniomedial course. The mean duct diameter was from proximal to distal 3.04 +/- 1.89mm at MP1, 2.38 +/- 1.23 mm at MP2, and 2.11 +/- 0.84 mm at MP3. In ventrodorsal radiographs of endoscopic retrograde pancreatography, the left and right branch of the accessory pancreatic duct united in the pancreatic body. The mean diameter of the right branch was 0.88 +/- 0.14 mm at MP1, 0.72 +/- 0.2 mm at MP2 and 0.61 +/- 0.11 mm at MP3. The left branch had a diameter of 0.93 +/- 0.28 mm at MP1, 0.86 +/- 0.21 at MP2, and 0.6 +/- 0.07 mm at MP3. The mean length was 81.6 +/- 14.3 mm for the right and 107.0 +/- 24.9mm for the left branch. In left lateral radiographs of endoscopic retrograde pancreatography, it was not possible to differentiate the left from the right branch. Both branches ran nearly parallel and showed similar diameters but slight differences in length. The study proves that endosopic retrograde cholangio-pancreatography is possible in dogs. Radiographs taken from dogs in dorsal recumbency allow an objective assessment of the common bile duct and the accessory pancreatic duct.  相似文献   
3.

Objective

To describe suspected adverse drug reactions in cats associated with use of α2-adrenoceptor agonists.

Study design

Retrospective study.

Animals

A total of 90 cats.

Methods

Data were collected from reports on adverse reactions to veterinary medicines sent to the Finnish Medicines Agency during 2003–2013. All reports of suspected adverse reactions associated with use of α2-adrenoceptor agonists in cats were included. Probable pulmonary oedema was diagnosed based on post mortem or radiological examination, or presence of frothy or excess fluid from the nostrils or trachea. If only dyspnoea and crackles on auscultation were reported, possible pulmonary oedema was presumed.

Results

Pulmonary oedema was suspected in 61 cases. Of these cats, 37 were categorised as probable and 24 as possible pulmonary oedema. The first clinical signs had been noted between 1 minute and 2 days (median, 15 minutes) after α2-adrenoceptor agonist administration. Many cats probably had no intravenous overhydration when the first clinical signs were detected, as either they presumably had no intravenous cannula or the signs appeared before, during or immediately after cannulation. Of the 61 cats, 43 survived, 14 died and for four the outcome was not clearly stated.

Conclusions and clinical relevance

Pulmonary oedema is a perilous condition that may appear within minutes of an intramuscular administration of sedative or anaesthetic agent in cats. The symptoms were not caused by intravenous overhydration, at least in cats having no venous cannula when the first clinical signs were detected.  相似文献   
4.
This paper introduces case study analysis against an illustrative model, the ‘house model’, which contains a number of key elements for sustaining participatory forest management (PFM). In theory, the elements in the model are basic requirements for ensuring that the participation of local people in forest management will continue after external donor support ceases. In practice, the study shows that none of the four case study projects managed to build the whole ‘house’ nor did they have tangible impacts on all the elements, and long-term sustainability of PFM is still questionable. All four donor-supported projects had limited tangible impacts on access to information and benefits, especially with regards to long-term extension services, markets and marketing information. These were the most difficult elements to influence during and after the projects in all four cases. It is concluded that in order to sustain PFM, there needs to be a solid institutional foundation which as a minimum ensures local people’s access to information and benefits from forests under the PFM.  相似文献   
5.
A progressive pulmonary disease resulting in severe respiratory failure and death in an average of 3 weeks was diagnosed in 11 young Dalmatian dogs. The dogs were from 4 litters, all genetically related by a common ancestor. The initial clinical signs were tachypnea and noisy respiration. Respiratory distress developed shortly before death and was characterized by strenuous and rapid respirations, along with cyanosis and vomiting. On blood gas analysis, there were severe arterial hypoxemia, hypercapma, and marked alveolar-arterial oxygen difference. Radiographically, a diffuse pattern of alveolar, interstitial, and peribronchial densities was observed in the lungs. Most dogs developed pneumomediastinum and gastroesophageal intussusception in the terminal phase of the disease. There was no response to treatment with antibiotics, corticosteroids, diuretics, or oxygen. At necropsy, the lungs were wet, heavy, and relatively airless. Absence of 1 kidney in 2 dogs and severe internal hydrocephalus in 2 dogs were additional necropsy findings. Pulmonary histopathology included metaplasia and atypia of the alveolar and bronchiolar epithelium, a nonpurulent inflammatory reaction characterized mainly by mononuclear cells and macrophages, eosinophilic hyaline membrane formation, and focal pulmonary fibrosis. The histological manifestations were typical of acute lung injury. Clinically, the findings were consistent with adult respiratory distress syndrome (ARDS), except for the relatively long course. No known risk factors for ARDS, such as trauma, toxin exposure, infection, or endotoxemia could be identified. The relationship of the other abnormalities (ie, renal aplasia, hydrocephalus) to the pulmonary disease also remains obscure. An inherited defect is suspected, because segregation analysis of the 4 litters suggests autosomal recessive inheritance.  相似文献   
1
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号